Key Events This Week
16 Mar: Mojo Grade downgraded to Sell amid mixed financial and technical signals
16 Mar: Mildly bearish technical shift confirmed with mixed momentum indicators
19 Mar: Sharp intraday decline of 2.02% on heavy volume
20 Mar: Slight recovery with 0.32% gain, week closes at Rs.5,257.75

Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals
2026-03-16 08:11:08Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 13 March 2026. This revision reflects a combination of deteriorating technical indicators, flat recent financial performance, and concerns over long-term growth prospects despite solid management efficiency and fair valuation metrics.
Read full news article
Alkem Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals
2026-03-16 08:02:39Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock exhibits a complex interplay of technical indicators, reflecting both cautious investor sentiment and pockets of resilience.
Read full news article
Alkem Laboratories Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals
2026-03-13 08:02:24Alkem Laboratories Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from a mildly bullish trend to a sideways movement. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the pharmaceutical mid-cap continues to demonstrate resilience amid mixed signals from MACD, RSI, and moving averages, reflecting a complex market environment for investors.
Read full news article
Alkem Laboratories Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals
2026-03-11 08:03:15Alkem Laboratories Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting cautious optimism for investors in the Pharmaceuticals & Biotechnology sector.
Read full news article
Alkem Laboratories Ltd is Rated Hold by MarketsMOJO
2026-03-10 10:10:02Alkem Laboratories Ltd is currently rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article








